Complete pathological regression of hepatocellular carcinoma with portal vein thrombosis treated with sorafenib. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue World Journal of Surgical Oncology Année : 2013

Complete pathological regression of hepatocellular carcinoma with portal vein thrombosis treated with sorafenib.

Résumé

Sorafenib is a molecular-targeted therapy used in palliative treatment of advanced hepatocellular carcinoma (HCC) in Child-Pugh A patients. We describe the case of a patient who presented with a large HCC in the left liver associated with portal vein thrombosis (PVT). After 9 months of sorafenib treatment, reassessment showed that the tumors had decreased in size with recanalization of the portal vein. A lateral left hepatectomy was performed and pathology showed complete necrosis of the tumor. Sorafenib can downstage HCC in patients with cirrhosis allowing further surgical resection.

Domaines

Chirurgie Cancer
Fichier principal
Vignette du fichier
1477-7819-11-171.pdf (1.32 Mo) Télécharger le fichier
1477-7819-11-171.xml (30.12 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Format : Autre
Loading...

Dates et versions

inserm-00850497 , version 1 (06-08-2013)

Identifiants

Citer

Sabrina Kermiche-Rahali, Aude Di Fiore, Fanny Drieux, Frédéric Di Fiore, Arnaud François, et al.. Complete pathological regression of hepatocellular carcinoma with portal vein thrombosis treated with sorafenib.. World Journal of Surgical Oncology, 2013, 11 (1), pp.171. ⟨10.1186/1477-7819-11-171⟩. ⟨inserm-00850497⟩
255 Consultations
265 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More